uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Targeting the PDGF signaling pathway in tumor treatment
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Ludwig Institute for Cancer Research. Uppsala University, Science for Life Laboratory, SciLifeLab.
2013 (English)In: Cell Communication and Signaling, ISSN 1478-811X, E-ISSN 1478-811X, Vol. 11, 97- p.Article, review/survey (Refereed) Published
Abstract [en]

Platelet-derived growth factor (PDGF) isoforms and PDGF receptors have important functions in the regulation of growth and survival of certain cell types during embryonal development and e.g. tissue repair in the adult. Overactivity of PDGF receptor signaling, by overexpression or mutational events, may drive tumor cell growth. In addition, pericytes of the vasculature and fibroblasts and myofibroblasts of the stroma of solid tumors express PDGF receptors, and PDGF stimulation of such cells promotes tumorigenesis. Inhibition of PDGF receptor signaling has proven to useful for the treatment of patients with certain rare tumors. Whether treatment with PDGF/PDGF receptor antagonists will be beneficial for more common malignancies is the subject for ongoing studies.

Place, publisher, year, edition, pages
2013. Vol. 11, 97- p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-215587DOI: 10.1186/1478-811X-11-97ISI: 000329172500001PubMedID: 24359404OAI: oai:DiVA.org:uu-215587DiVA: diva2:687681
Available from: 2014-01-15 Created: 2014-01-15 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

fulltext(514 kB)134 downloads
File information
File name FULLTEXT01.pdfFile size 514 kBChecksum SHA-512
f7dff6d881311ec56cf13deb0527b0cf27f9fa85440c46a1cf1fc3f5d47ec8ff5d90293383a92fd9f2a3097951a2281845aa83bf66e63c94425c0d4c45475c1e
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Heldin, Carl-Henrik

Search in DiVA

By author/editor
Heldin, Carl-Henrik
By organisation
Ludwig Institute for Cancer ResearchScience for Life Laboratory, SciLifeLab
In the same journal
Cell Communication and Signaling
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 134 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 378 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf